Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.

, 81 infliximab naive RA patients and 47 healthy subjects as controls. At the same time and apart from the purposes of that study, we also had done a pathergy test in those subjects who agreed to participate, with the aim of determining the effect of the pathergy phenomenon on the response of BS patients to the tuberculin test. Informed consent was obtained from all subjects. The study was appr...

متن کامل

Refractory Sweet's syndrome successfully treated with rituximab

IL: interleukin PG: pyoderma gangrenosum RA: rheumatoid arthritis SS: Sweet’s syndrome TNF: tumor necrosis factor INTRODUCTION Sweet’s syndrome (SS) is a neutrophilic dermatosis characterized by an abrupt onset of painful erythematous cutaneous lesions that have a neutrophilic infiltrate typically located in the papillary dermis. Fever and an elevated neutrophil count can accompany the cutaneou...

متن کامل

Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide.

Shrinking lung syndrome (SLS) is an uncommon feature of systemic lupus erythematosus (SLE) characterized by dyspnea, pleuritic chest pain, diaphragmatic elevation, restrictive ventilatory defect and reduced respiratory muscle strength as measured by volitional tests. We report the case of a 28-year-old woman with overlapping features of SLE and Sjögren syndrome who developed severe SLS while re...

متن کامل

Immune thrombocytopenia induced by fludarabine successfully treated with rituximab.

Fludarabine is the most effective chemotherapeutic agent for chronic lymphocytic leukemia (CLL) whether used as a first or second-line therapy. The most common fludarabine toxicities are myelosuppression and immunodeficiency and consequent development of opportunistic infections . Other rare toxicities associated with fludarabine therapy are hemolytic anemia, pure red-cell aplasia, and immune t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Blood Advances

سال: 2018

ISSN: 2473-9529,2473-9537

DOI: 10.1182/bloodadvances.2018019000